Dr. Carl Barton Gillombardo, MD

Dr. Gillombardo practices at University Hospitals Ahuja Medical Center in Beachwood, Ohio, part of University Hospitals Health System.

Dr. Gillombardo's NPI, 1952758443, was assigned on May 16, 2016. Dr. Gillombardo holds Ohio license 35.136395.

Dr. Gillombardo's primary practice is University Hospitals Ahuja Medical Center, at 3999 Richmond Road, Beachwood, OH 44122 in Cuyahoga County. The practice phone is (216) 593-5511.

Dr. Gillombardo's primary practice is University Hospitals Ahuja Medical Center in Beachwood, Ohio, part of University Hospitals Health System. Dr. Gillombardo is also affiliated with Cleveland Clinic Main Campus. The medical group on file is University Hospitals Medical Practices. Dmand AI also links Dr. Gillombardo to 2 more hospitals, 2 hospital outpatient departments and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gillombardo practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Gillombardo's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Gillombardo is licensed in Ohio.

CMS data shows 152 Medicare services from Dr. Gillombardo across 4 procedure codes in 2024, for 94 Medicare patients. Medicare paid $20,336 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 94 Medicare patients who saw Dr. Gillombardo in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gillombardo's median patient age at 71, with 50% women.

In 2024, Dr. Gillombardo wrote 226 Medicare Part D claims for 76 patients. 93% of them were for generic drugs. CMS names the drug for 153 of them, across 7 drugs with 11 or more claims each, at $1,498 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Gillombardo for performance year 2024, reported as part of a group. Dr. Gillombardo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 90 general payments to Dr. Gillombardo from 21 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 82% of the total. Boston Scientific Corporation paid the most, $1,454. It also lists 2 research payments totaling $176 from 2023 to 2024.